- Enrollment in Stage 1 of Study A3921009 and have completed 6-months of treatment with
trial medications (CP-690,550 or tacrolimus)
- Recipient of a first-time kidney transplant
- Subject with any untreated condition that may affect drug absorption (eg, gastrectomy
or clinically significant diabetic gastroenteropathy).
- Subjects who are on the waiting list for a second kidney transplant or any non-renal